NORDIMET sol inj 22.5 mg/0.9ml ser pré
7680658390192
CH-65839
L04AX03
07.10.6.
Reimbursement limitations:
NORDIMET
N’est pas remboursé dans l’indication suivante : induction d’une rémission lors de la maladie de …
1 / 3
google
Details
- Product number
- 6583907
- CPT
- -
- Packaging group
- 1
- Unit
- Fertigspritze(n)
- Composition
- methotrexatum 22.5 mg ut methotrexatum natricum, natrii chloridum, natrii hydroxidum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml corresp. natrium max. 7.2 mg. Tela cum: alcohol isopropylicus.
Articles (1)
Nordimet 22.5 mg/0.9 ml, Injektionslösung in einer Fertigspritze
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
22.5 MG | Substance | Wirkstoff (Principe actif) |
|
TEL
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 37.55
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/02/2017
Authorization holder
Nordic Pharma GmbH
8050 Zürich
Authorization information
- Swissmedic authorization number
- 65839
- Drug name
- Nordimet, Injektionslösung in einer Fertigspritze
- Galenic form
- INLFS
- ATC Code
- L04AX03
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 21/10/2016
- Authorization expiration date
- 31/12/9999
- IT number
- 07.10.6.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NORDIMET sol inj 22.5 mg/0.9ml ser pré
- Description (DE)
- NORDIMET Inj Lös 22.5 mg/0.9ml Fertspr
- Market launch
- 21/10/2016
- Narcotic (BTM)
- No